Aclaris Therapeutics Inc (ACRS)
1.19
+0.02
(+1.71%)
USD |
NASDAQ |
Apr 25, 16:00
1.14
-0.05
(-4.20%)
After-Hours: 06:44
Aclaris Therapeutics Price to Book Value: 0.537 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 0.537 |
| April 24, 2024 | 0.5279 |
| April 23, 2024 | 0.5505 |
| April 22, 2024 | 0.5505 |
| April 19, 2024 | 0.5595 |
| April 18, 2024 | 0.555 |
| April 17, 2024 | 0.555 |
| April 16, 2024 | 0.5505 |
| April 15, 2024 | 0.546 |
| April 12, 2024 | 0.546 |
| April 11, 2024 | 0.5505 |
| April 10, 2024 | 0.5234 |
| April 09, 2024 | 0.537 |
| April 08, 2024 | 0.537 |
| April 05, 2024 | 0.537 |
| April 04, 2024 | 0.555 |
| April 03, 2024 | 0.564 |
| April 02, 2024 | 0.5505 |
| April 01, 2024 | 0.5686 |
| March 28, 2024 | 0.5595 |
| March 27, 2024 | 0.5686 |
| March 26, 2024 | 0.5325 |
| March 25, 2024 | 0.5234 |
| March 22, 2024 | 0.5189 |
| March 21, 2024 | 0.5415 |
| Date | Value |
|---|---|
| March 20, 2024 | 0.537 |
| March 19, 2024 | 0.5189 |
| March 18, 2024 | 0.5189 |
| March 15, 2024 | 0.5279 |
| March 14, 2024 | 0.5189 |
| March 13, 2024 | 0.564 |
| March 12, 2024 | 0.5505 |
| March 11, 2024 | 0.5821 |
| March 08, 2024 | 0.6362 |
| March 07, 2024 | 0.6092 |
| March 06, 2024 | 0.6498 |
| March 05, 2024 | 0.5731 |
| March 04, 2024 | 0.564 |
| March 01, 2024 | 0.5595 |
| February 29, 2024 | 0.537 |
| February 28, 2024 | 0.537 |
| February 27, 2024 | 0.5415 |
| February 26, 2024 | 0.546 |
| February 23, 2024 | 0.537 |
| February 22, 2024 | 0.546 |
| February 21, 2024 | 0.5415 |
| February 20, 2024 | 0.546 |
| February 16, 2024 | 0.537 |
| February 15, 2024 | 0.555 |
| February 14, 2024 | 0.5505 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.237
Minimum
Aug 14 2019
38.15
Maximum
Mar 22 2021
4.347
Average
3.573
Median
Dec 06 2021
Price to Book Value Benchmarks
| Aldeyra Therapeutics Inc | 1.937 |
| Akoya Biosciences Inc | 3.491 |
| MSP Recovery Inc | 0.0546 |
| Bullfrog AI Holdings Inc | 8.662 |
| Cadrenal Therapeutics Inc | 0.8815 |
Price to Book Value Related Metrics
| PS Ratio | 2.658 |
| Price | 1.19 |
| Earnings Yield | -106.7% |
| Market Cap | 84.40M |